In an era where misinformation can spread rapidly online, parents are often left grappling with conflicting advice about ...
It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV ... and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus ...
Results from a Phase 2 human challenge study of EDP-323, an RSV L-protein inhibitor ... the leading treatment regimens for curing chronic hepatitis c virus (HCV) infection and is sold by AbbVie ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results